Synergistic effects on dopamine cell death in a Drosophila model of chronic toxin exposure

NeuroToxicology

Volumn 44, Issue , 2014, Pages 344-351

  Martin, Ciara A ^a   Barajas, Angel ^b   Lawless, George ^b   Lawal, Hakeem O ^a,b,c   Assani, Khadij ^b   Lumintang, Yosephine P ^b   Nunez, Vanessa ^b   Krantz, David E ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DELAWARE STATE UNIVERSITY   (United States)

Author keywords

E1 ligase; Maneb; Paraquat; Parkinson's disease; Ubiquitin proteasome system; Ziram

Indexed keywords

ALDEHYDE DEHYDROGENASE; MANEB; PARAQUAT; PESTICIDE; UBIQUITIN PROTEIN LIGASE; UBIQUITIN PROTEIN LIGASE E1; UNCLASSIFIED DRUG; ZIRAM;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DEATH; CELL LOSS; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DROSOPHILA; ENZYME INHIBITION; LONG TERM EXPOSURE; MALE; MOTOR DYSFUNCTION; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PROTEIN TARGETING; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; UBIQUITINATION; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; DROSOPHILA MELANOGASTER; DRUG EFFECTS; METABOLISM; MOTOR ACTIVITY; SURVIVAL ANALYSIS;

ANIMALS; CELL DEATH; DISEASE MODELS, ANIMAL; DOPAMINERGIC NEURONS; DROSOPHILA MELANOGASTER; MANEB; MOTOR ACTIVITY; PARAQUAT; PARKINSON DISEASE, SECONDARY; PESTICIDES; SURVIVAL ANALYSIS; UBIQUITIN-PROTEIN LIGASES; ZIRAM;

EID: 84908500771     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2014.08.005     Document Type: Article

References (68)

1. Auluck P.K., Chan H.Y., Trojanowski J.Q., Lee V.M., Bonini N.M. Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease. Science 2002, 295:865-868.
2. Auluck P.K1, Meulener M.C., Bonini N.M. Mechanisms of suppression of alpha-synuclein neurotoxicity by geldanamycin in Drosophila. J Biol Chem 2005, 280:2873-2878.
3. Belote J.M., Fortier E. Targeted expression of dominant negative proteasome mutants in Drosophila melanogaster. Genesis 2002, 34:80-82.
4. Benzer S. Behavioral mutants of Drosophila isolated by countercurrent distribution. Proc Natl Acad Sci 1967, 58:1112-1119.
5. Beyer K., Ariza A. Alpha-synuclein posttranslational modification and alternative splicing as a trigger for neurodegeneration. Mol Neurobiol 2013, 47:509-524.
6. Bonilla E., Medina-Leendertz S., Dìaz S. Extension of life span and stress resistance of Drosophila melanogaster by long-term supplementation with melatonin. Exp Gerontol 2002, 37:629-638.
7. Bonilla-Ramirez L., Jimenez-Del-Rio M., Velez-Pardo C. Low doses of paraquat and polyphenols prolong life span and locomotor activity in knock-down Parkin Drosophila melanogaster exposed to oxidative stress stimuli: implication in autosomal recessive juvenile Parkinsonism. Gene 2013, 512:355-363.
8. Calabrese E.J. Hormesis and medicine. Br J Clin Pharmacol 2008, 66:594-617.
9. Chakraborty M., Fry J.D. Drosophila lacking a homologue of mammalian aldh2 have multiple fitness defects. Chemico-Biol Inter 2011, 191:296-302.
10. Chaudhuri A., Bowling K., Funderburk C., Lawal H., Inamdar A., Wang Z., et al. Interaction of genetic and environmental factors in a Drosophila Parkinsonism model. J Neurosci 2007, 27:2457-2467.
11. Chin L.S., Fau O.J., Li L. Parkin-mediated ubiquitin signalling in aggresome formation and autophagy. Biochem Soc Trans 2010, 38:144-149.
12. Chou A.P., Maidment N., Klintenberg R., Casida J.E., Li S., Fitzmaurice A.G., et al. Ziram causes dopaminergic cell damage by inhibiting E1 ligase of the proteasome. J Biol Chem 2008, 283:34696-34703.
13. Cicchetti F., Lapointe N., Roberge-Tremblay A., Saint-Pierre M., Jimenez L., Ficke B.W., et al. Systemic exposure to paraquat and maneb models early Parkinson's disease in young adult rats. Neurobiol Dis 2005, 20:360-371.
14. Costello S., Cockburn M., Bronstein J., Zhang X., Ritz B. Parkinson's disease and residential exposure to maneb and paraquat from agricultural applications in the Central Valley of California. Am J Epidemiol 2009, 169:919-926.
15. Coulom H., Birman S. Chronic exposure to rotenone models sporadic Parkinson's disease in Drosophila melanogaster. J Neurosci 2004, 24:10993-10998.
16. DiAntonio A., Hicke L. Ubiquitin-dependent regulation of the synapse. Annu Rev Neurosci 2004, 27:223-246.
17. Doorn J.A., Florang V.R., Schamp J.H., Vanle B.C. Aldehyde dehydrogenase inhibition generates a reactive dopamine metabolite autotoxic to dopamine neurons. Parkinsonism Relat Disord 2014, 20(Suppl 1):S5-S73.
18. Ebrahimi-Fakhari D., Wahlster L., McLean P. Protein degradation pathways in Parkinson's disease: curse or blessing. Acta Neuropathol 2012, 124:153-172.
19. Fitzmaurice A.G. The role of pesticide-induced aldehyde dehydrogenase inhibition in the pathogenesis of Parkinson's disease. Doctoral Dissertation 2012, California Institute of Technology.
20. Fitzmaurice A.G., Rhodes S.L., Cockburn R.B., Bronstein J.M. Aldehyde dehydrogenase variation enhances effect of pesticides associated with Parkinson disease. Neurology 2014, 82:419-426.
21. Fitzmaurice A.G., Rhodes S.L., Lulla A., Murphy N.P., Lam H.A., O'Donnell K.C., et al. Aldehyde dehydrogenase inhibition as a pathogenic mechanism in Parkinson disease. Proc Natl Acad Sci 2013, 110:636-641.
22. Fry J.D., Saweikis M. Aldehyde dehydrogenase is essential for both adult and larval ethanol resistance in Drosophila melanogaster. Genet Res 2006, 87:87-92.
23. Giordano E., Rendina R., Peluso I., Furia M. RNAi triggered by symmetrically transcribed transgenes in Drosophila melanogaster. Genetics 2002, 160:637-648.
24. Goldman S.M. Environmental toxins and Parkinson's disease. Annu Rev Pharmacol Toxicol 2014, 54:141-164.
25. Grotewiel M.S., Martin I., Bhandari P., Cook-Wiens E. Functional senescence in Drosophila melanogaster. Ageing Res Rev 2005, 4:372-397.
26. Guo M. What have we learned from Drosophila models of Parkinson's disease?. Progress in brain research 2010, 2-16. Elsevier. B. Anders, M.A. Cenci (Eds.).
27. Hamilton A.M., Zito K. Breaking it down: the ubiquitin proteasome system in neuronal morphogenesis. Neural Plastic 2013, 2013:10.
28. Hosamani R. Muralidhara Acute exposure of Drosophila melanogaster to paraquat causes oxidative stress and mitochondrial dysfunction. Arch Insect Biochem Physiol 2013, 83:25-40.
29. Humphreys J.M., Hilliker A.J., Phillips J.P. Paraquat selection identifies x-linked oxygen defense genes in Drosophila melanogaster. Genome 1993, 36:162-165.
30. Kleiger G., Mayor T. Perilous journey: a tour of the ubiquitin-proteasome system. Trends Cell Biol 2014, 24:352-359.
31. Kordower J.H., Kanaan N.M., Chu Y., Suresh Babu R., Stansell J., Terpstra B.T., et al. Failure of proteasome inhibitor administration to provide a model of Parkinson's disease in rats and monkeys. Ann Neurol 2006, 60:264-268.
32. Lawal H.O., Chang H.Y., Terrell A.N., Brooks E.S., Pulido D., Simon A.F., et al. The Drosophila vesicular monoamine transporter reduces pesticide-induced loss of dopaminergic neurons. Neurobiol Dis 2010, 40:102-112.
33. Lawal H.O., Terrell A., Lam H.A., Djapri C., Jang J., Hadi R., et al. Drosophila modifier screens to identify novel neuropsychiatric drugs including aminergic agents for the possible treatment of Parkinson's disease and depression. Mol Psychiatry 2014, 19:235-242.
34. Lee J.-Y., Nagano Y., Taylor J.P., Lim K.L., Yao T.-P. Disease-causing mutations in Parkin impair mitochondrial ubiquitination, aggregation, and hdac6-dependent mitophagy. J Cell Biol 2010, 189:671-679.
35. Legan S.K., Rebrin I., Mockett R.J., Radyuk S.N., Klichko V.I., Sohal R.S., et al. Overexpression of glucose-6-phosphate dehydrogenase extends the life span of Drosophila melanogaster. J Biol Chem 2008, 283:32492-32499.
36. Li H., Chaney S., Forte M., Hirsh J. Ectopic G-protein expression in dopamine and serotonin neurons blocks cocaine sensitization in Drosophila melanogaster. Curr Biol 2000, 10:211-214.
37. Li X., Matsumoto K., Murakami Y., Tezuka Y., Wu Y., Kadota S. Neuroprotective effects of polygonum multiflorum on nigrostriatal dopaminergic degeneration induced by paraquat and maneb in mice. Pharmacol Biochem Behav 2005, 82:345-352.
38. Liou H.-H., Chen R.-C., Tsai Y.-F., Chen W.-P., Chang Y.-C., Tsai M.-C. Effects of paraquat on the substantia nigra of the wistar rats: neurochemical, histological, and behavioral studies. Toxicol Appl Pharmacol 1996, 137:34-41.
39. Marchitti S.A., Deitrich R.A., Vasiliou V. Neurotoxicity and metabolism of the catecholamine-derived 3,4-dihydroxyphenylacetaldehyde and 3,4-dihydroxyphenylglycolaldehyde: the role of aldehyde dehydrogenase. Pharmacol Rev 2007, 59:125-150.
40. Matsui H., Ito H., Taniguchi Y., Inoue H., Takeda S., Takahashi R. Proteasome inhibition in medaka brain induces the features of Parkinson's disease. J Neurochem 2010, 115:178-187.
41. McCormack A.L., Thiruchelvam M., Manning-Bog A.B., Thiffault C., Langston J.W., Cory-Slechta D.A., et al. Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat. Neurobiol Dis 2002, 10:119-127.
42. McNaught K.S.P., Perl D.P., Brownell A-L., Olanow C.W. Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease. Ann Neurol 2004, 56:149-162.
43. Neuburger P.J., Saville K.J., Zeng J., Smyth K.-A., Belote J.M. A genetic suppressor of two dominant temperature-sensitive lethal proteasome mutants of Drosophila melanogaster is itself a mutated proteasome subunit gene. Genetics 2006, 173:1377-1387.
44. Olanow C.W., McNaught K.S.P. Ubiquitin-proteasome system and Parkinson's disease. Movement Disord 2006, 21:1806-1823.
45. Pandey U.B., Nie Z., Batlevi Y., McCray B.A., Ritson G.P., Nedelsky N.B., et al. HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 2007, 447:859-863.
46. Rinetti G.V., Schweizer F.E. Ubiquitination acutely regulates presynaptic neurotransmitter release in mammalian neurons. J Neurosci 2010, 30:3157-3166.
47. Robinow S., White K. Characterization and spatial distribution of the elav protein during Drosophila melanogaster development. J Neurobiol 1991, 22:443-461.
48. Rzezniczak T.Z., Douglas L.A., Watterson J.H., Merritt T.J.S. Paraquat administration in Drosophila for use in metabolic studies of oxidative stress. Anal Biochem 2011, 419:345-347.
49. Schapira A.H.V. Mitochondrial pathology in Parkinson's disease. Mount Sinai J Med J Transl Personal Med 2011, 78:872-881.
50. Schmidt M., Finley D. Regulation of proteasome activity in health and disease. Mol Cell Res 2014, 1843:13-25.
51. Schulz T.J., Zarse K., Voigt A., Urban N., Birringer M., Ristow M. Glucose restriction extends Caenorhabditis elegans life span by inducing mitochondrial respiration and increasing oxidative stress. Cell Metab 2007, 6:280-293.
52. Schweisguth F. Dominant-negative mutation in the β2 and β6 proteasome subunit genes affect alternative cell fate decisions in the Drosophila sense organ lineage. Proc Natl Acad Sci 1999, 96:11382-11386.
53. Shackleford B. Reregistration eligibility decision for ziram pc code: 034805 case:2180; 2003. http://www.epa.gov/oppsrrd1/REDs/ziram_red.pdf.
54. Shen M., Lipsky J., Naylor S. Role of disulfiram in the in vitro inhibition of rat liver mitochondrial aldehyde dehydrogenase. Biochem Pharmacol 2000, 60:947-953.
55. Shin M., Jan C., Jacquard C., Jarraya B., Callebert J., Launay J.-M., et al. Chronic systemic treatment with a high-dose proteasome inhibitor in mice produces akinesia unrelated to nigrostriatal degeneration. Neurobiol Aging 2011, 32:2100-2102.
56. Shukla A.K., Pragya P., Chaouhan H.S., Tiwari A.K., Patel D.K., Abdin M.Z., et al. Heat shock protein-70 (Hsp-70) suppresses paraquat-induced neurodegeneration by inhibiting JNK and caspase-3 activation in Drosophila model of Parkinson's disease. PLoS One 2014, 9:e98886.
57. Simon A.F., Liang D.T., Krantz D.E. Differential decline in behavioral performance of Drosophila melanogaster with age. Mech Ageing Dev 2006, 127:647-651.
58. Simon A.F.S.C.A.S. Steroid control of longevity in Drosophila melanogaster. Science 2003, 299:1407.
59. Srivastava G., Dixit A., Yadav S., Patel D.K., Prakash O., Singh M.P. Resveratrol potentiates cytochrome P450 2 d22-mediated neuroprotection in maneb- and paraquat-induced Parkinsonism in the mouse. Free Radic Biol Med 2012, 52:1294-1306.
60. Staub R.E., Quistad G.B., Casida J.E. Mechanism for benomyl action as a mitochondrial aldehyde dehydrogenase inhibitor in mice. Chem Res Toxicol 1998, 11:535-543.
61. Staub R.E., Sparks S.E., Quistad G.B., Casida J.E. S-methylation as a bioactivation mechanism for mono- and dithiocarbamate pesticides as aldehyde dehydrogenase inhibitors. Chem Res Toxicol 1995, 8:1063-1069.
62. Sulzer D. Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease. Trends Neurosci 2007, 30:244-250.
63. Thiruchelvam M., Brockel B., Richfield E., Baggs R., Cory-Slechta D. Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: environmental risk factors for Parkinson's disease. Brain Res 2000, 873:225-234.
64. Thrash B., Uthayathas K.S.S., Suppiramaniam V., Dhanasekaran M. Paraquat and maneb induced neurotoxicity. Proc West Pharmacol Soc 2007, 50:31-42.
65. Wang A., Costello S., Cockburn M., Zhang X., Bronstein J., Ritz B. Parkinson's disease risk from ambient exposure to pesticides. Eur J Epidemiol 2011, 1-9.
66. Wang X.-F., Li S., Chou A.P., Bronstein J.M. Inhibitory effects of pesticides on proteasome activity: implication in Parkinson's disease. Neurobiol Dis 2006, 23:198-205.
67. Wey M.C-Y., Fernandez E., Martinez P.A., Sullivan P., Goldstein D.S., Strong R. Neurodegeneration and motor dysfunction in mice lacking cytosolic and mitochondrial aldehyde dehydrogenases: implications for Parkinson's disease. PLoS One 2012, 7:e31522.
68. Zhang J., Fitsanakis V., Gu G., Jing D., Ao M.F., Amarnath V., et al. Manganese ethylene-bis-dithiocarbamate and selective dopaminergic neurodegeneration in rat: a link through mitochondrial dysfunction. J Neurochem 2003, 84:336-346.